ARCHIVES

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

USPSTF Delivers “D” Recommendation For Ovarian Cancer Screening

September 28, 2012

In Brief: Transition Team Denies It Is Seeking New NCI Director; Garb Undergoes Surgery At M.D.A

November 28, 1980

NCI News: Biospecimen Banks Program for NCTN

November 22, 2013

NCI Study Finds No Greater Cancer Risk Near Nuclear Plants

September 28, 1990

NSABP Submits Appeal To NIH To Reverse Cancellation Of P-4 Chemoprevention Trial.

August 10, 2007

Hepatitis B Vaccine Almost Ready, Blumberg Tells Science Writers

April 10, 1981